RUSSO, EMILIO
 Distribuzione geografica
Continente #
NA - Nord America 290
EU - Europa 262
AS - Asia 49
Totale 601
Nazione #
US - Stati Uniti d'America 290
IE - Irlanda 140
SE - Svezia 100
CN - Cina 25
SG - Singapore 20
IT - Italia 11
BE - Belgio 3
IN - India 3
CZ - Repubblica Ceca 2
FR - Francia 2
DE - Germania 1
FI - Finlandia 1
GB - Regno Unito 1
NL - Olanda 1
TR - Turchia 1
Totale 601
Città #
Dublin 140
Chandler 100
Nyköping 80
Ashburn 23
Princeton 22
Medford 21
Singapore 9
Beijing 7
Des Moines 7
Messina 7
Jacksonville 5
Shenyang 5
Brussels 3
Dearborn 3
Falls Church 3
Fuzhou 3
Hyderabad 3
Brno 2
Cambridge 2
Haikou 2
Jinan 2
Los Angeles 2
New York 2
Seattle 2
Zhengzhou 2
Amsterdam 1
Ann Arbor 1
Boardman 1
Catania 1
Changsha 1
Chicago 1
Francofonte 1
Guangzhou 1
Hangzhou 1
Munich 1
San Mateo 1
Taizhou 1
Vicenza 1
Washington 1
Totale 471
Nome #
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 59
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 49
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 47
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 45
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 37
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 35
Genetics of reflex seizures and epilepsies in humans and animals 34
Management of status epilepticus in patients with liver or kidney disease: a narrative review 26
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide 25
Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study 23
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 22
Diagnostic Biomarkers of Epilepsy 22
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 22
Epilepsy associated with Leukoaraiosis mainly affects temporal lobe: a casual or causal relationship? 21
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis 20
Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study 20
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 19
Epilepsy and Immune System: A Tour Around the Current Literature 18
Profile of brivaracetam and its potential in the treatment of epilepsy 18
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 16
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy 15
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 14
An empirical investigation of the unbiased forward exchange rate hypothesis in a regime switching market 13
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 1
Totale 621
Categoria #
all - tutte 3.154
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 1 0 4 1 0 0 6 0 2
2020/202135 1 0 9 0 5 0 0 10 8 0 2 0
2021/202294 1 8 0 1 4 2 6 0 2 16 4 50
2022/2023373 24 62 23 19 8 39 2 12 174 2 6 2
2023/202474 5 20 5 20 5 7 0 2 0 4 0 6
2024/202520 18 2 0 0 0 0 0 0 0 0 0 0
Totale 621